A detailed history of Strategic Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Strategic Asset Management, LLC holds 578 shares of ABBV stock, worth $104,040. This represents 0.14% of its overall portfolio holdings.

Number of Shares
578
Previous 578 -0.0%
Holding current value
$104,040
Previous $89,000 12.36%
% of portfolio
0.14%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $4,619 - $5,731
-35 Reduced 5.71%
578 $94,000
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $9,131 - $11,554
85 Added 16.1%
613 $83,000
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $56,179 - $63,771
528 New
528 $59,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Strategic Asset Management, LLC Portfolio

Follow Strategic Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Asset Management, LLC with notifications on news.